Status:
UNKNOWN
A Cohort of Patients With Chronic Pulmonary Disease
Lead Sponsor:
The First Affiliated Hospital of Guangzhou Medical University
Conditions:
Obstructive Pulmonary Disease
Eligibility:
All Genders
18-80 years
Brief Summary
This is a longitudinal study of following chronic pulmonary disease patients to observe and predict the clinical outcomes of these patients.
Detailed Description
In patients with chronic pulmonary disease, impaired pulmonary function and limited exercise capacity, is a complex clinical syndrome with a wide range of underlying causes, which may result in worse ...
Eligibility Criteria
Inclusion
- Age 18-80, males and females
- Patients are diagnosed as the obstructive pulmonary disease according to the clinical practice.
- Willing to participate in the study.
- Being able to provide informed consent.
Exclusion
- Subjects with severe heart failure, severe arrhythmias, unstable angina, and malignant comorbidities.
- Subjects with significantly impaired cognitive function and are unable to fulfill the study requirement (unable to provide informed consent)
- Subjects who participated in another trial within 30 days prior to the planned start of the study
- Subjects with cancer or have had cancer in the 5 years prior to study entry.
Key Trial Info
Start Date :
August 22 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04050943
Start Date
August 22 2019
End Date
September 1 2021
Last Update
October 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangzhou Institute of Respiratory Disease
Guangzhou, Guangdong, China, 510000